The Novel Allele, HLA‐B*41:92 , Identified by Next‐Generation Sequencing in a Saudi Individual
HLA · 2026-01 · 107 (1)
DOI: 10.1111/tan.70545 ↗At a glance
Journal article in HLA, published online on 2025-12-29. Written by Shaima Alkebasi and 4 co-authors. Institution: Histocompatibility & Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia. Major MEDLINE topics: Alleles, Exons, High-Throughput Nucleotide Sequencing, HLA-B Antigens. Cited 2 times so far (Crossref); 2 references.
Abstract (original language)
The novel allele HLA‐B*41:92 differs from HLA‐B*41:02:01:01 by a single non‐synonymous substitution in exon 4.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Histocompatibility & Immunogenetics Laboratory, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
ORCID profiles: Mohammad Awaji
Cite
APA
Alkebasi, S., AlZahrani, S., AlAithan, M., Mohammed, A., & Awaji, M. (2026). The Novel Allele, HLA‐B*41:92 , Identified by Next‐Generation Sequencing in a Saudi Individual. HLA, 107(1). https://doi.org/10.1111/tan.70545
Vancouver
Alkebasi S, AlZahrani S, AlAithan M, Mohammed A, Awaji M. The Novel Allele, HLA‐B*41:92 , Identified by Next‐Generation Sequencing in a Saudi Individual. HLA. 2026;107(1). doi:10.1111/tan.70545
BibTeX
@article{Alkebasi2026,
author = {Alkebasi, Shaima and AlZahrani, Saber and AlAithan, Mohammed and Mohammed, Amani and Awaji, Mohammad},
title = {The Novel Allele, HLA‐B*41:92 , Identified by Next‐Generation Sequencing in a Saudi Individual},
journal = {HLA},
year = {2026},
volume = {107},
number = {1},
doi = {10.1111/tan.70545}
}
EUVIMED